Injective Surges on MiCA Filing and ETF Progress
The price of Injective (INJ) surged by 3.68% in one hour due to a combination of regulatory and ecosystem-expansion catalysts, not a single event.
The MiCA whitepaper for INJ was filed, listing it in ESMA's Interim MiCA Register covering 30 EU markets. This is an early regulatory step, reducing legal uncertainty for exchanges and custodians that want to list or support the token under MiCA.
In parallel, Canary Capital amended its proposed 'Canary Staked INJ ETF' on June 25, 2026, which aims to hold INJ and stake it on-chain. The filing describes a trust reflecting the value of INJ held, with staking rewards as a secondary objective.